Israel Englander Biomarin Pharmaceutical Inc Put Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $3.8 Million - $5.16 Million	55,000 Added 401.46%	68,700 $4.83 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $1.32 Million - $1.64 Million	-17,800 Reduced 56.51%	13,700 $1.13 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $2.64 Million - $3.12 Million	-31,500 Reduced 50.0%	31,500 $2.75 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $4.8 Million - $6.21 Million	63,000 New	63,000 $6.07 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $11 Million - $14.7 Million	125,300 New	125,300 $12.2 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.